4.7 Article

CaMKIIβ Regulates Oligodendrocyte Maturation and CNS Myelination

期刊

JOURNAL OF NEUROSCIENCE
卷 33, 期 25, 页码 10453-10458

出版社

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.5875-12.2013

关键词

-

资金

  1. National Institutes of Health-National Institute of Neurological Disorders and Stroke
  2. National Multiple Sclerosis Society
  3. European Leukodystrophies Association
  4. National Institutes of Health-National Institute of Neurological Disorders and Stroke Center Core Grant [5 P30 NS047463]

向作者/读者索取更多资源

CNS myelination and the maturation of the myelinating cells of the CNS, namely oligodendrocytes, are thought to be regulated by molecular mechanisms controlling the actin cytoskeleton. However, the exact nature of these mechanisms is currently only poorly understood. Here we assessed the role of calcium/calmodulin-dependent kinase type II (CaMKII), in particular CaMKII beta, in oligodendrocyte maturation and CNS myelination. Using in vitro culture studies, our data demonstrate that CaMKII beta is critical for the proper morphological maturation of differentiating oligodendrocytes, an aspect of oligodendrocyte maturation that is mediated to a large extent by changes in the cellular cytoskeleton. Furthermore, our data provide evidence for an actin-cytoskeleton-stabilizing role of CaMKII beta in differentiating oligodendrocytes. Using Camk2b knock-out and Camk2b(A303R) mutant mice, our data revealed an in vivo functional role of CaMKII beta in regulating myelin thickness that may be mediated by a non-kinase-catalytic activity. Our data point toward a critical role of CaMKII beta in regulating oligodendrocyte maturation and CNS myelination via an actin-cytoskeleton-regulatory mechanism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Developmental

Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1

Jesminne Castricum, Joke H. M. Tulen, Walter Taal, Andre B. Rietman, Ype Elgersma

Summary: In this study, adults with NF1 performed similarly to controls in attention and motor learning tasks, with the only difference being shorter reaction times in controls. Measures of attention or motor learning were not significantly associated with reduced intellectual performance in NF1. These findings contrast with previous studies in children with NF1 and suggest potential differences in cognitive functioning between pediatric and adult NF1 populations.

JOURNAL OF ATTENTION DISORDERS (2022)

Article Biochemistry & Molecular Biology

RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity

Martina Proietti Onori, Linda M. C. Koene, Carmen B. Schaefer, Mark Nellist, Marcel de Brito van Velze, Zhenyu Gao, Ype Elgersma, Geeske M. van Woerden

Summary: The study utilized a mouse model expressing RHEBp.P37L in the somatosensory cortex to uncover the mechanism underlying epilepsy caused by mTOR pathway hyperactivation, revealing that enhanced axonal connectivity leads to hyperexcitability in distal neurons. Blocking axonal vesicle release from RHEBp.P37L neurons alone effectively stopped seizures and normalized the hyperexcitability of distant neurons.

PLOS BIOLOGY (2021)

Article Genetics & Heredity

MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders

Sarah C. Borrie, Ellen Plasschaert, Zsuzsanna Callaerts-Vegh, Akihiko Yoshimura, Rudi D'Hooge, Ype Elgersma, Steven A. Kushner, Eric Legius, Hilde Brems

Summary: The study found that Spred1-/- mice exhibit changes in social and communicative behaviors, and pharmacological targeting of the Ras-MAPK pathway can reverse these behavioral phenotypes. Through research on mouse models, it was revealed that dysregulation of the Ras-MAPK signaling pathway plays a key role in mediating social behavior phenotypes in ASD mouse models.

MOLECULAR AUTISM (2021)

Article Medicine, Research & Experimental

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model

Claudia Milazzo, Edwin J. Mientjes, Ilse Wallaard, Soren Vestergaard Rasmussen, Kamille Dumong Erichsen, Tejaswini Kakunuri, A. S. Elise van der Sman, Thomas Kremer, Meghan T. Miller, Marius C. Hoener, Ype Elgersma

Summary: Research findings demonstrate that ASO-induced reactivation of UBE3A in AS mice can lead to positive effects on AS phenotypes, such as restored sensitivity to seizures and improvements in behavior, indicating therapeutic potential.

JCI INSIGHT (2021)

Article Psychiatry

Cortical Inhibition and Plasticity in Major Depressive Disorder

Jesminne Castricum, Tom K. Birkenhager, Steven A. Kushner, Ype Elgersma, Joke H. M. Tulen

Summary: This study investigated inhibitory neurotransmission and cortical plasticity in MDD patients and controls using TMS technology, finding deficits in cortical plasticity in MDD patients. However, no significant differences in cortical inhibition were observed in depressed patients, suggesting that reduced cortical inhibition may not be a robust correlate of the pathophysiological mechanism in MDD.

FRONTIERS IN PSYCHIATRY (2022)

Article Medicine, Research & Experimental

Identifying the temporal electrophysiological and molecular changes that contribute to TSC-associated epileptogenesis

Linda Mc Koene, Eva Niggl, Ilse Wallaard, Martina Proietti-Onori, Diana C. Rotaru, Ype Elgersma

Summary: The study utilized an inducible Tsc1-knockout mouse model to examine the electrophysiological and molecular changes during Tsc1-induced epileptogenesis. Deletion of Tsc1 led to hippocampus-specific changes in excitability and adaptation, which were rescued by early treatment with the mTOR inhibitor rapamycin. Transcriptome analysis revealed significant transcriptional changes during epileptogenesis, with the potential involvement of ion channels in driving epileptogenesis. These findings suggest that targeting the TSC/mTOR signaling pathway may be a promising therapeutic approach for epilepsy in individuals with TSC.

JCI INSIGHT (2021)

Article Medicine, Research & Experimental

Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice

Matthew C. Judson, Charles Shyng, Jeremy M. Simon, Courtney R. Davis, A. Mattijs Punt, Mirabel T. Salmon, Noah W. Miller, Kimberly D. Ritola, Ype Elgersma, David G. Amaral, Steven J. Gray, Benjamin D. Philpot

Summary: Loss of maternal UBE3A allele leads to Angelman syndrome (AS), a severe neurodevelopmental disorder. Reinstating dual-isoform expression of human UBE3A in the developing brain through gene transfer significantly improved motor learning and innate behaviors in AS mice, demonstrating the therapeutic potential of this approach.

JCI INSIGHT (2021)

Review Genetics & Heredity

From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research

F. Isabella Zampeta, Ben Distel, Ype Elgersma, Rik Iping

Summary: This study reviews the development of Angelman syndrome research over the past 50 years using a bibliometric approach. The results reveal a shift in research focus towards genetic therapies for Angelman syndrome and provide insights into changes in funding sources, publishing journals, and international collaborations.

HUMAN GENETICS (2022)

Article Biochemistry & Molecular Biology

A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets

Nikhil J. Pandya, Sonja Meier, Stefka Tyanova, Marco Terrigno, Congwei Wang, A. Mattijs Punt, E. J. Mientjes, Audrey Vautheny, Ben Distel, Thomas Kremer, Ype Elgersma, Ravi Jagasia

Summary: This study investigates the mechanisms and potential therapeutic options for Angelman syndrome. Proteomics analysis reveals changes in protein pathways during different stages of development in an AS mouse model. Restoring UBE3A expression is shown to reverse these changes and provide a promising treatment option. Additionally, a novel UBE3A substrate is discovered, and a protein database is created to support future research.

MOLECULAR PSYCHIATRY (2022)

Article Neurosciences

A Novel Automated Approach for Improving Standardization of the Marble Burying Test Enables Quantification of Burying Bouts and Activity Characteristics

Lucas Wahl, A. Mattijs Punt, Tara Arbab, Ingo Willuhn, Ype Elgersma, Aleksandra Badura

Summary: The marble burying test is commonly used to describe behaviors in mouse models of neurodevelopmental and psychiatric disorders. A new automated method using machine learning algorithms was introduced to quantify burying behavior in freely moving mice. The accuracy of the method was confirmed in three mouse models, showing consistent results with previously reported phenotypes. The study also revealed additional information about mouse activity during the test.

ENEURO (2022)

Article Genetics & Heredity

The MAP3K7 gene: Further delineation of clinical characteristics and genotype/phenotype correlations

Geeske M. van Woerden, Richelle Senden, Charlotte de Konink, Rossella A. Trezza, Anwar Baban, Jennifer A. Bassetti, Yolande van Bever, Lynne M. Bird, Bregje W. van Bon, Alice S. Brooks, Qiaoning Guan, Eric W. Klee, Carlo Marcelis, Joel M. Rosado, Lisa A. Schimmenti, Amy R. Shikany, Paulien A. Terhal, Kathryn Nicole Weaver, Marja W. Wessels, Hester van Wieringen, Anna C. Hurst, Catherine F. Gooch, Katharina Steindl, Pascal Joset, Anita Rauch, Marco Tartaglia, Marcello Niceta, Ype Elgersma, Serwet Demirdas

Summary: This study identifies clinical phenotypes associated with MAP3K7 gene mutations, confirming the correlation between different mutation types and phenotypes in FMD2 and CSCF, and highlighting the importance of considering MAP3K7 mutations in the differential diagnosis of cardiac defects, connective tissue disorders, and NS.

HUMAN MUTATION (2022)

Article Psychiatry

Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome

Joseph K. Tanas, Devante D. Kerr, Li Wang, Anika Rai, Ilse Wallaard, Ype Elgersma, Michael S. Sidorov

Summary: Angelman syndrome (AS) is a neurodevelopmental disorder that affects motor function, cognition, and sleep, among other comorbidities. Multidimensional analysis has been used to quantify the behavioral profiles of AS mice, accurately predicting their genotype and evaluating the effectiveness of treatment.

TRANSLATIONAL PSYCHIATRY (2022)

Article Medicine, Research & Experimental

Molecular and behavioral consequences of Ube3a gene overdosage in mice

A. Mattijs Punt, Matthew C. Judson, Michael S. Sidorov, Brittany N. Williams, Naomi S. Johnson, Sabine Belder, Dion den Hertog, Courtney R. Davis, Maximillian S. Feygin, Patrick F. Lang, Mehrnoush Aghadavoud Jolfaei, Patrick J. Curran, Wilfred F. J. van Ijcken, Ype Elgersma, Benjamin D. Philpot

Summary: Chromosome 15q11.2-q13.1 duplication syndrome (Dup15q syndrome) is a severe neurodevelopmental disorder characterized by intellectual disability, impaired motor coordination, and autism spectrum disorder. While overexpression of the UBE3A gene is presumed to be the main cause of Dup15q pathology, studies on mouse models with UBE3A overexpression have yielded conflicting results. In this study, transgenic mouse models were used to investigate the neurodevelopmental impact of Ube3a gene overdosage and found limited effects on neurodevelopment, but increased mortality when faced with seizures.

JCI INSIGHT (2022)

Meeting Abstract Biochemistry & Molecular Biology

The Dutch Center of RNA Therapeutics: developing mutation-specific antisense oligonucleotide therapies for patients with eye and brain diseases carrying unique mutations

A. Aartsma-Rus, M. Lauffer, R. Collin, Y. Elgersma, W. van Roon-Mom

FEBS OPEN BIO (2022)

Article Genetics & Heredity

Clinical aspects of a large group of adults with Angelman syndrome

Inge den Besten, Rianne F. de Jong, Amber Geerts-Haages, Hennie T. Bruggenwirth, Marije Koopmans, Alice Brooks, Ype Elgersma, Dederieke A. M. Festen, Marlies J. Valstar

Summary: This study describes the clinical phenotypes of Angelman syndrome (AS) in adults, revealing significant health issues such as constipation, reflux, visual problems, scoliosis, behavioral problems, and sleeping problems. Epilepsy was reported in 57% of adults with AS, impacting their level of functioning. A decline in mobility was noted in the majority of adults, with a minority showing microcephaly.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

暂无数据